Abstract: Considerable research achievements have been made in utilizing information granulation as an effective technique for addressing long-term time-series forecasting. However, existing studies ...

Abstract: Undoubtedly, machine learning (ML) has demonstrated a wealth of far-reaching successes present both at the level of fundamental developments, design methodologies and numerous application ...

Share price of Granules India hit a 52-week high of ₹626.85, gaining 2 per cent on the BSE in Wednesday’s intra-day trade. The stock price of the pharmaceutical company surpassed its previous high of ...

Granules India Board on Tuesday approved the drugmaker’s proposals to raise ₹1,762.50 crore through issue of preferential convertible warrants and equity shares. The company plans to issue 2.5 crore ...

https://www.thehindubusinessline.com/markets/stock-markets/granules-india-to-raise-176250-crore/article70428757.ece Copy The board of directors of Granules India ...

The board of Granules India Ltd. has approved plans to raise up to ₹1,462.50 crore through the issuance of convertible warrants. The company will raise the funds by issuing 2.50 crore convertible ...

Granules India, through a subsidiary, has received U.S. Food and Drug Administration’s (FDA’s) tentative approval for its generic of attention deficit hyperactivity disorder drug Adzenys-XR-ODT. The ...

Shares of Granules India Ltd. are in focus on Monday, December 22, after the company said its wholly-owned subsidiary Granules Pharmaceuticals Inc. received tentative approval from the US drug ...

Hyderabad: Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug ...

FDA flags five procedural observations, no data integrity or product safety issues. Granules India on 19 December 2025 said its wholly owned subsidiary, Granules Life Sciences, has completed a Good ...

Telangana: Granules India has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with five observations at the Hyderabad facility of Granules Life Sciences, a ...